Conservative versus Interventional Treatment for Spontaneous Pneumothorax. Brown SGA et al. N Engl J Med. 2020 Jan 30;38…
この記事を読む
記事一覧 28ページ
この記事を読む
ALK-TKIはPD後もプラチナ＋ペメトレキセドと併用した方がよい？
Efficacy of Platinum/Pemetrexed Combination Chemotherapy in ALK-Positive NSCLC Refractory to Second-Generation ALK Inhib…
この記事を読む
多発か肺内転移かの鑑別アルゴリズム
A Novel Algorithm to Differentiate Between Multiple Primary Lung Cancers and Intrapulmonary Metastasis in Multiple Lung …
この記事を読む
オシメルチニブ耐性、治療するほど多様化
Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimert…
この記事を読む
LCNECの治療は小細胞癌レジメンがbetter
Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center r…
この記事を読む
ベバシズマブ＋ペメトレキセドの維持療法
Randomized Phase III Study of Continuation Maintenance Bevacizumab With or Without Pemetrexed in Advanced Nonsquamous No…
この記事を読む
ROS1陽性に対するエヌトレクチニブ
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials. Drilon A …
この記事を読む
EGFRm+の脳病変フォローアップはどうするべきか
Effects of different brain surveillance strategies on outcomes for patients with EGFR-mutant metastatic lung adenocarcin…
この記事を読む
メトホルミンはTKIの効果を上げる？
Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations…
この記事を読む
Uncommon mutationに対するオシメルチニブ
Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, P…